210 related articles for article (PubMed ID: 26689065)
1. [Transdermal System-Buprenorphine and Fentanyl].
Sakurai H
Masui; 2015 Nov; 64(11):1145-50. PubMed ID: 26689065
[TBL] [Abstract][Full Text] [Related]
2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain.
Wolff RF; Aune D; Truyers C; Hernandez AV; Misso K; Riemsma R; Kleijnen J
Curr Med Res Opin; 2012 May; 28(5):833-45. PubMed ID: 22443154
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of transdermal buprenorphine and transdermal fentanyl in the treatment of neuropathic pain in AIDS patients.
Canneti A; Luzi M; Di Marco P; Cannata F; Pasqualitto F; Spinoglio A; Reale C
Minerva Anestesiol; 2013 Aug; 79(8):871-83. PubMed ID: 23558760
[TBL] [Abstract][Full Text] [Related]
5. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Sittl R; Likar R; Nautrup BP
Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
[TBL] [Abstract][Full Text] [Related]
6. A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report.
Leppert W
Am J Hosp Palliat Care; 2014 Feb; 31(1):101-4. PubMed ID: 23349342
[TBL] [Abstract][Full Text] [Related]
7. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
8. Transdermal opioids for cancer pain.
Skaer TL
Health Qual Life Outcomes; 2006 Mar; 4():24. PubMed ID: 16573839
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of a long-acting transdermal fentanyl solution compared to buprenorphine for the control of postoperative pain in dogs in a randomized, multicentered clinical study.
Linton DD; Wilson MG; Newbound GC; Freise KJ; Clark TP
J Vet Pharmacol Ther; 2012 Aug; 35 Suppl 2():53-64. PubMed ID: 22731776
[TBL] [Abstract][Full Text] [Related]
10. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
Mitra F; Chowdhury S; Shelley M; Williams G
Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.
Grond S; Radbruch L; Lehmann KA
Clin Pharmacokinet; 2000 Jan; 38(1):59-89. PubMed ID: 10668859
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.
Plosker GL
Drugs; 2011 Dec; 71(18):2491-509. PubMed ID: 22141389
[TBL] [Abstract][Full Text] [Related]
13. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
[TBL] [Abstract][Full Text] [Related]
14. [Understanding Oral and Nasal Mucosal Absorption of Fentanyl, and Rectal Absorption of Buprenorphine].
Shimoyama N; Shimoyama M; Kubota Y; Kato Y
Masui; 2015 Nov; 64(11):1160-5. PubMed ID: 26689067
[TBL] [Abstract][Full Text] [Related]
15. The transdermal delivery of fentanyl.
Lane ME
Eur J Pharm Biopharm; 2013 Aug; 84(3):449-55. PubMed ID: 23419814
[TBL] [Abstract][Full Text] [Related]
16. Alternatives to oral opioids for cancer pain.
Mercadante S; Fulfaro F
Oncology (Williston Park); 1999 Feb; 13(2):215-20, 225; discussion 226-9. PubMed ID: 10079471
[TBL] [Abstract][Full Text] [Related]
17. Transdermal buprenorphine.
Evans HC; Easthope SE
Drugs; 2003; 63(19):1999-2010; discussion 2011-2. PubMed ID: 12962515
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of Durogesic in moderate to severe, nonmalignant, chronic pain in Germany.
Greiner W; Lehmann K; Earnshaw S; Bug C; Sabatowski R
Eur J Health Econ; 2006 Dec; 7(4):290-6. PubMed ID: 16983521
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study on the effect of buprenorphine and fentanyl on descending pain modulation: a human experimental study.
Arendt-Nielsen L; Andresen T; Malver LP; Oksche A; Mansikka H; Drewes AM
Clin J Pain; 2012 Sep; 28(7):623-7. PubMed ID: 22156892
[TBL] [Abstract][Full Text] [Related]
20. Transdermal opioids for cancer pain.
Cachia E; Ahmedzai SH
Curr Opin Support Palliat Care; 2011 Mar; 5(1):15-9. PubMed ID: 21325999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
